Codexis Aktsia

Codexis P/B

P/B (hinna ja raamatupidamisliku väärtuse suhe) ettevõttest Codexis (CDXS) seisuga 16. aug 2026 on 2,15. Eelmisel aastal oli P/B (hinna ja raamatupidamisliku väärtuse suhe) 1,62 — muutus 32,45% (kõrgem).

P/B

2,15

YoY

32,45%

Viimati uuendatud:

P/B (hinna ja raamatupidamisliku väärtuse suhe) ettevõttest Codexis on 2026 2,15 . P/B (hinna ja raamatupidamisliku väärtuse suhe) ettevõttest Codexis oli 2025 1,62 . See väheneb 32,45% kõrgem võrreldes eelmise aastaga.
Access this data via the Eulerpool API

Codexis Aktsiate analüüs

Mida Codexis teeb? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis on üks populaarsemaid ettevõtteid Eulpoolist.

Sageli esitatud küsimused Codexis aktsia kohta

Codexis P/B (hinna ja raamatupidamisliku väärtuse suhe) on 2026. aastal 2,15.

P/B (hinna ja raamatupidamisliku väärtuse suhe) ettevõttest Codexis muutus 1,62 -st 2,15 -ks, mis vastab 32,45% muutusele. Väärtus on kõrgem kui eelmisel aastal.

Eulpoolist leiate P/B (hinna ja raamatupidamisliku väärtuse suhe) Codexis täieliku ajaloolise arengu alates 2006. aastast – koos aastate väärtustega, graafikutega ja üksikasjalike analüüsidega.

Hinna ja raamatupidamisliku väärtuse suhe võrdleb ettevõtte turuhinda tema raamatupidamislikuga. Madal P/B võib näidata alakursiga aktsiat, samas kõrge P/B võib viidata ülehinnanguele või tugevatele kasvuootustele.

P/B = aktsiakurs / raamatupidamislik väärtus aktsia kohta

P/B (hinna ja raamatupidamisliku väärtuse suhe) hindamiseks on oluline võrrelda seda sama tööstuse ja sektori ettevõtetega. Eulpoolis leiate P/B (hinna ja raamatupidamisliku väärtuse suhe) jaoks otsesed tööstusesisesed võrdlused.

Hea väärtus varieerub tööstuse ja ettevõtte arenguetapi järgi. Eulpoolis saate P/B (hinna ja raamatupidamisliku väärtuse suhe) Codexis võrrelda sektori konkurentidega ja tööstuse keskmisega, et hinnata selle atraktiivsust.

Access this data via the Eulerpool API

Hindamine — Codexis

Kõik finantsnäitajad — Codexis